Mark Gilbert

Mark Gilbert, M.D. was previously Chief Medical Officer at Juno Therapeutics. Prior to joining Juno, Dr. Gilbert served as an interim Chief Medical Officer and consultant in strategic drug development and portfolio management in medical oncology for several U.S. biotechnology and pharmaceutical companies. Prior to these positions, Dr. Gilbert was a faculty member at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle and trained in the laboratory of Dr. Phil Greenberg, one of Juno’s scientific co-founders. Dr. Gilbert earned a BS degree in biochemistry from the University of Iowa and an MD from the University of Iowa Medical School in Iowa City, Iowa. Dr. Gilbert also serves as chair of Inceptor Bio's Scientific Advisory Board.